Scinovex
articleTop 1% cited

Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing

Science Translational Medicine · 2011 · Vol. 3(65) · pp. 65ra4–65ra4
Callum J. BellDarrell L. DinwiddieNeil MillerShannon HateleyElena E. GanusovaJoann MudgeRay J. LangleyLu ZhangClarence LeeFaye SchilkeyVrunda ShethJimmy E. WoodwardHeather E. PeckhamGary P. SchrothRyan W. KimStephen F. Kingsmore

Abstract

Of 7028 disorders with suspected Mendelian inheritance, 1139 are recessive and have an established molecular basis. Although individually uncommon, Mendelian diseases collectively account for ~20% of infant mortality and ~10% of pediatric hospitalizations. Preconception screening, together with genetic counseling of carriers, has resulted in remarkable declines in the incidence of several severe recessive diseases including Tay-Sachs disease and cystic fibrosis. However, extension of preconception screening to most severe disease genes has hitherto been impractical. Here, we report a preconception carrier screen for 448 severe recessive childhood diseases. Rather than costly, complete sequencing of the human genome, 7717 regions from 437 target genes were enriched by hybrid capture or microdroplet polymerase chain reaction, sequenced by next-generation sequencing (NGS) to a depth of up to 2.7 gigabases, and assessed with stringent bioinformatic filters. At a resultant 160x average target coverage, 93% of nucleotides had at least 20x coverage, and mutation detection/genotyping had ~95% sensitivity and ~100% specificity for substitution, insertion/deletion, splicing, and gross deletion mutations and single-nucleotide polymorphisms. In 104 unrelated DNA samples, the average genomic carrier burden for severe pediatric recessive mutations was 2.8 and ranged from 0 to 7. The distribution of mutations among sequenced samples appeared random. Twenty-seven percent of mutations cited in the literature were found to be common polymorphisms or misannotated, underscoring the need for better mutation databases as part of a comprehensive carrier testing strategy. Given the magnitude of carrier burden and the lower cost of testing compared to treating these conditions, carrier screening by NGS made available to the general population may be an economical way to reduce the incidence of and ameliorate suffering associated with severe recessive childhood disorders.

Genomics and Rare DiseasesCystic Fibrosis Research AdvancesImmunodeficiency and Autoimmune DisordersCarrier testingDNA sequencingGenetic testingMedicineDiseasePredictive valueGeneticsBiologyGeneInternal medicine

MeSH terms

Base SequenceChildFemaleGenes, RecessiveGenetic TestingHeterozygoteGenetic Carrier ScreeningHumansMolecular Sequence DataMutationPregnancyPrenatal DiagnosisGenome, HumanSequence AlignmentSequence Analysis, DNA
Citations
706
FWCI
52.20
field-weighted impact
References
66
Percentile
100%
vs. same field & year
Citations per year
Cited by
Exome sequencing as a tool for Mendelian disease gene discovery
Nature Reviews Genetics · 2011 · 1,675 citations
Precision Medicine: From Science To Value
Health Affairs · 2018 · 738 citations
InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines
The American Journal of Human Genetics · 2017 · 1,074 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.